|
|
|
Stem Cell Related Patent Number US6143292
| Title: | Allogeneic cell therapy for cancer following allogeneic stem cell transplantation | | Inventors: | Slavin, Shimon; Jerusalem, Israel | | Summary: | Described herein are allogeneic lymphocytes and methods of their use. The invention relates to a process of administering allogeneic lymphocytes in the treatment of a human cancer patient having a solid malignant tumor. Specific therapeutic applications are provided, such as for inducing a graft-versus-tumor response in the treatment of solid tumors and leukemia with allogeneic lymphocytes after allogeneic stem cell transplantation. | | Abstract: | A method of treating a human cancer patient having a solid tumor comprising malignant cells is disclosed, wherein the patient having undergone a cancer therapy regimen comprising allogeneic stem cell transplantation. The method comprises administering allogeneic lymphocytes to the patient and monitoring the patient for levels of malignant cells. | | US Patent Website: | Click Here for Full Text of Patent | | Title Number: | US6143292 | | Application Number: | US1997000930071 | | Date Filed: | 21/11/1997 | | Date Published: | 07/11/2000 | | Assignee: | Baxter International Inc., Deerfield, IL, USA |
|
|
